StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)

Close on Nov 17, 2026Market cap $740.91MP/E –Yield –

Cytek Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Cytek Biosciences

Cytek Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cytek Biosciences figures

See a number that looks wrong?